KR101388918B1 - Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it - Google Patents
Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it Download PDFInfo
- Publication number
- KR101388918B1 KR101388918B1 KR1020120055971A KR20120055971A KR101388918B1 KR 101388918 B1 KR101388918 B1 KR 101388918B1 KR 1020120055971 A KR1020120055971 A KR 1020120055971A KR 20120055971 A KR20120055971 A KR 20120055971A KR 101388918 B1 KR101388918 B1 KR 101388918B1
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- lactic acid
- fermentation
- lactobacillus
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 12
- 239000000203 mixture Substances 0.000 title claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 title abstract description 6
- 239000000463 material Substances 0.000 title description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 84
- 241000894006 Bacteria Species 0.000 claims abstract description 42
- 239000004310 lactic acid Substances 0.000 claims abstract description 42
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 42
- 241000186660 Lactobacillus Species 0.000 claims abstract description 39
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 37
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 238000000855 fermentation Methods 0.000 abstract description 42
- 230000004151 fermentation Effects 0.000 abstract description 42
- 230000000694 effects Effects 0.000 abstract description 25
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 8
- 229930014626 natural product Natural products 0.000 abstract description 7
- 230000001766 physiological effect Effects 0.000 abstract description 7
- 230000002087 whitening effect Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000010828 elution Methods 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 description 12
- 244000005700 microbiome Species 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 229930182494 ginsenoside Natural products 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000006872 mrs medium Substances 0.000 description 5
- 229940089161 ginsenoside Drugs 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 241000186605 Lactobacillus paracasei Species 0.000 description 2
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000021001 fermented dairy product Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000012771 pancakes Nutrition 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 인체에서 유래한 유산균 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 및 그 활용 방안에 관한 것으로, 더욱 상세하게는 천연물 발효를 통해 생리활성 증진 활성을 가질 뿐 아니라 미백 효과 및 노화방지와 관련된 항산화 효능까지 갖는 유산균 락토바실러스 람노서스 HK-9와 그를 이용한 발효물 및 화장제품에 관한 것이다.
본 발명에 따른 유산균은 일반 식품이 아닌 인체에서 유래한 균주이기 때문에 식품 발효뿐만 아니라 미백 등의 활성에 매우 효과적이다. 이를 통해 기존의 천연물에서 용출되지 않거나 매우 적은 양이 용출되어 발효 효율이 떨어지는 문제점을 극복하여 유효물질을 효과적으로 용출할 수 있고, 화장품의 원료로서의 효과까지 거둘 수 있다.The present invention relates to a lactic acid bacterium Lactobacillus rhamnosus strain HK-9 derived from a human body and a utilization method thereof, and more particularly to a lactic acid bacterium strain Lactobacillus rhamnosus strain HK-9 having a physiological activity enhancing activity through natural product fermentation, Lactobacillus lambosus HK-9 having an antioxidant effect and a fermented product and cosmetic product using the same.
The lactic acid bacterium according to the present invention is a strain derived from a human body, not a general food, and thus is very effective for activity such as whitening as well as food fermentation. As a result, it is possible to effectively dissolve the effective substance by overcoming the problem that it is not eluted from the existing natural product or the elution of a very small amount and the fermentation efficiency is inferior, and the effect as a raw material for cosmetics can be obtained.
Description
본 발명은 인체에서 유래한 유산균 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 및 그 활용 방안에 관한 것으로, 더욱 상세하게는 천연물 발효를 통해 생리활성 증진 활성을 가질 뿐 아니라 미백 효과 및 노화방지와 관련된 항산화 효과를 갖는 유산균 락토바실러스 람노서스 HK-9와 그를 이용한 발효물 및 화장제품에 관한 것이다.The present invention relates to a lactic acid bacterium Lactobacillus rhamnosus strain HK-9 derived from a human body and a utilization method thereof, and more particularly to a lactic acid bacterium strain Lactobacillus rhamnosus strain HK-9 having a physiological activity enhancing activity through natural product fermentation, Lactobacillus Lambosus HK-9 having an antioxidative effect and a fermented product and a cosmetic product using the same.
본 발명에 따른 유산균은 일반 식품이 아닌 인체에서 유래한 균주이기 때문에 식품 발효뿐만 아니라 미백 등 활성에 매우 효과적이다. 이를 통해 기존의 천연물에서 용출되지 않거나 매우 적은 양이 용출되어 발효 효율이 떨어지는 문제점을 극복하여 유효물질을 효과적으로 용출할 수 있고, 화장품의 원료로서의 효과까지 거둘 수 있다.
Since the lactic acid bacterium according to the present invention is a strain derived from a human body, not a general food, it is very effective for activity such as whitening as well as food fermentation. As a result, it is possible to effectively dissolve the effective substance by overcoming the problem that it is not eluted from the existing natural product or the elution of a very small amount and the fermentation efficiency is inferior, and the effect as a raw material for cosmetics can be obtained.
유산균(Lactobacillus)은 치즈, 발효유 및 유산균 음료 등의 발효 유제품을 비롯하여 각종 발효 식품의 제조에 전 세계적으로 광범위하게 응용되고 있는 중요한 미생물이다.Lactobacillus ( Lactobacillus ) is an important microorganism widely used worldwide in the production of various fermented foods including fermented dairy products such as cheese, fermented milk and lactic acid bacteria drink.
유산균은 식품 산업의 발효 및 장질환에 대한 치료와 예방의 정장 효과를 목적으로 오랫동안 사용되어 발전을 거듭하였다. 유산균의 활용에 대한 보고로는 여러 편이 나와 있다. 그 예로서, 유아기 설사 증상에 유산균을 투여하여 치료 효과를 보았다는 보고(R.O. Clock, J.A.M.A. Vol. 61, P.164, 1913)가 있은 이래, 설사 증세로 고통 받는 환자의 70%를 치료하였다는 보고(L.M. Gornpertz, et al., J.A.M.A. Vol. 80, P.90, 1923), 장내 유해균의 증식을 저해하고 유익한 균의 생장에 좋은 조건을 만들어 주어 식중독의 방지, 장내 부패방지, 변비예방, 면역력의 증가, 발암 억제 등의 여러 가지 생리적 기능을 가진다는 내용 등이 밝혀지고 있다.Lactic acid bacteria have been developed and used for a long time in order to effect the dressing effect of treatment and prevention of fermentation and intestinal diseases in the food industry. There are several reports on the use of lactic acid bacteria. As an example, 70% of patients suffering from diarrhea have been treated since they reported that they were treated with lactic acid bacteria for infantile diarrhea (RO Clock, JAMA Vol. 61, P.164, 1913) (LM Gornpertz, et al., JAMA Vol. 80, P. 90, 1923), inhibiting the growth of intestinal noxious bacteria and providing favorable conditions for the growth of beneficial bacteria to prevent food poisoning, prevent intestinal decline, prevent constipation, , And that it has various physiological functions such as inhibition of carcinogenesis.
이러한 유산균을 이용한 발효물은 요구르트나 치즈와 같은 형태로 제품화되거나 김치, 청국장과 같은 식품산업에 크게 영향을 미치고 있다.Fermented products using these lactic acid bacteria are produced in the form of yogurt or cheese, or have a great influence on the food industry such as kimchi and chonggukjang.
한편 일반 유산균을 이용하여 제품을 발효시킬 경우 발효 제품의 풍미 및 발효 중에 생산되는 각종 생리활성 물질의 생산에 한계가 있는 것이 사실이다. 또한 유산균의 종류에 따라서 천연물 발효 시 발효 수율이 달라질 수 있으며, 어떤 것은 식품에 사용하고 향장 활성을 띠는 것은 화장품의 원료 활용하기도 하는 등, 유산균 종류에 따라 발효에 대한 활성과 쓰임새가 다른 것 또한 사실이다. 그런데 이러한 기능성을 보유한 발효물을 생산하기 위해 사용되는 유산균은 그 대부분의 발효균주를 외국에서 수입하고 있으며, 유산균의 출처도 치즈 등의 발효된 유제품에서 분리한 균주이다.On the other hand, when a product is fermented using a common lactic acid bacterium, there is a limit to the production of various physiologically active substances produced during the fermentation and fermentation of the fermented product. In addition, depending on the type of lactic acid bacteria, the yield of fermentation can be changed when fermenting natural products. Some of them are used for foods, and the fermentation activity is used for cosmetics. It is true. However, most of the lactic acid bacteria used for producing the fermented product having such functionality are imported from foreign countries, and the source of lactic acid bacteria is a strain isolated from fermented dairy products such as cheese.
따라서 발효 능력이 뛰어난 신규한 유산균의 확보는 경제적으로 매우 큰 파급효과를 가질 수 있다 할 것인바, 본 발명진은 음식은 사람의 손맛이라는 말과 여자 손에 유산균이 많이 존재한다는 점에 착안하여[실제로 여자 손에 유산균이 많이 존재한다는 보고가 있다(The influence of sex handedness and washing on the diversity of hand surface bacteria, PNAS 105(46) 17994-17999)] 여자 손에 많이 존재하는 균들을 동정하여 생리 활성 실험을 실시하였으며, 그중 Lactobacillus 속의 균을 분리하여 신규한 발효 유산균인 락토바실러스 람노서스 HK-9를 분리해 냈다.Therefore, securing new lactic acid bacteria having excellent fermentation ability can have a very large economic effect on economics. Therefore, the present inventors have focused on the fact that the food is the taste of man's hand and that lactic acid bacteria are present in the hands of women [ In fact, there are reports that lactic acid bacterium is present in many female hands (PNAS 105 (46) 17994-17999). The bacteria that are present in many female hands are identified and their physiological activity Lactobacillus strain Lactobacillus strain HK-9, which is a novel fermented lactic acid bacterium, was isolated.
본 발명진이 분리해낸 유산균 락토바실러스 람노서스 HK-9는 여자 손이 남자 손보다 곱다는 점에 착안하여 여자 손에서 분리해낸 유산균으로, 검사 결과 남자 손에서는 발견되지 않고 여자 손에서만 발견이 되었다. 위 균주는 유산균 본연의 기능인 발효 능력 외에도 미백 등의 활성 능력까지 갖는다는 점을 검증하였는데, 이는 여자 손에서만 검출되는 현상과 관련이 있는 것으로 보인다.Lactobacillus Lactobacillus Lymphosus HK-9 isolated from the present invention is a lactic acid bacterium isolated from a woman's hand in view of the fact that the female hand is more exquisite than that of the male hand. In addition to fermentation ability, which is a function of lactic acid bacteria, the strain has activity to whitening and so on.
보통의 유산균은 식품에서 얻어낸 균주가 대부분이기 때문에 식품 발효에 많이 사용하지만 본 발명자가 동정해낸 균주는 식품 및 화장품에 모두 적용할 수 있다.
The usual lactic acid bacteria are mostly used for food fermentation since most of the strains obtained from food are used, but the strains identified by the present inventor can be applied to foods and cosmetics.
위에서 기재한 바에 의하여 충분히 시사되었지만, 본 발명의 목적은 천연물 발효와 화장품에 모두 이용할 수 있는 신규한 미생물을 제공하는 데 있다.Although it has been fully illustrated by the above description, the object of the present invention is to provide a novel microorganism which can be used both for fermentation of natural materials and for cosmetics.
발명자들은 위 목적에 부합하는 균주를 분리하고 이를 이용하여 천연물 발효를 통한 유효 생리활성의 증가 및 발효 수율의 향상을 확인하고 미백 효과까지 검증하였다.
The present inventors isolated the strains corresponding to the above purposes and confirmed the increase of the effective physiological activity and the improvement of the yield of fermentation through the fermentation of natural materials and verified the whitening effect.
상기와 같은 본 발명은 인체에서 분리한 유산균 락토바실러스 람노서스 HK-9(기탁번호: KCCM11254P)인 것을 특징으로 한다.The present invention as described above is characterized in that the lactic acid bacteria Lactobacillus lambosus HK-9 (accession number: KCCM11254P) isolated from a human body.
본 발명은 또한 상기 유산균으로 발효한 발효물인 것을 특징으로 한다.The present invention is also characterized in that it is a fermented product fermented with the above-mentioned lactic acid bacteria.
또한 상기 유산균으로부터 추출한 액(유산균 자체의 추출액)을 함유하는 화장료 조성물인 것을 특징으로 한다. 이때 상기 유산균 자체의 추출액은, MRS 배지에서 배양된 락토바실러스 람노서스 HK-9 균주(기탁번호: KCCM11254P)를 원심분리하여 균주를 확보하고, 그 얻어진 균주를 초음파 처리하여 파쇄한 후, 이를 열수 추출 하여 얻어진 것임을 특징으로 한다.And a liquid (extract of the lactic acid bacteria itself) extracted from the lactic acid bacteria. At this time, the extract of the lactic acid bacteria itself was obtained by centrifuging the Lactobacillus lambosus strain HK-9 (accession number: KCCM11254P) cultured in the MRS medium to obtain a strain, subjecting the obtained strain to ultrasonic treatment, And the like.
또한 본 발명은 전술한 발효물을 함유하는 화장료 조성물 또는 식품인 것을 특징으로 한다.
Further, the present invention is characterized in that it is a cosmetic composition or food containing the above-mentioned fermented product.
본 발명은 여자 손으로부터 분리해낸 락토바실러스 람노서스 HK-9에 관한 것으로, 기존의 일반 유산균보다 천연물 발효를 통한 유효 생리활성 물질의 생산이 증대되어 발효 효과가 뛰어나고 미백 효과 및 노화방지와 관련된 항산화 효능까지 가지므로, 식품 및 화장품 소재의 원료로 공급되어 경제적으로 큰 파급 효과를 가질 수 있다.
The present invention relates to Lactobacillus lambosus strain HK-9 isolated from a woman's hand. The present invention relates to an anti-oxidant effect , It can be supplied as a raw material for food and cosmetic materials and can have a large economic impact.
도 1은 한국미생물보존센터에서 검사한 락토바실러스 람노서스 HK-9의 분석 결과로서, 위 균주의 16S rDNA 염기서열이다.
도 2는 락토바실러스 람노서스 HK-9의 계통분류학적 위치를 나타낸 도면이다.
도 3은 락토바실러스 람노서스 HK-9의 SEM 사진을 찍어 유산균의 형태학적 모습을 나타낸 도면이다.
도 4는 MRS 배지를 이용한 락토바실러스 람노서스 HK-9의 시간에 따른 균체 농도를 나타낸 도면이다.
도 5는 락토바실러스 람노서스 HK-9 균주 및 다른 일반 균주의 발효에 따른 인삼의 진세노사이드 함량을 나타낸 도면이다.
도 6은 락토바실러스 람노서스 HK-9를 이용하여 발효한 더덕에서 새로운 물질이 생성된 결과를 나타낸 도면이다.
도 7은 상기 발효 더덕의 발효 전후의 DPPH 활성 결과를 나타낸 도면이다.
도 8과 9는 락토바실러스 람노서스 HK-9 균주 자체의 미백 관련 효능 실험을 나타낸 결과로, 도 8은 멜라닌 합성 저해능(Melanin synthesis inhibition activity) 실험, 도 9는 티로시네이즈 저해(Tyrosinase inhibition) 실험 결과를 나타낸 도면이다.FIG. 1 shows the 16S rDNA sequence of the strain of Lactobacillus lambosus HK-9, which was examined by the Korean Microorganism Preservation Center.
Fig. 2 is a diagram showing phylogenetic locations of Lactobacillus lambatus HK-9.
Fig. 3 is a diagram showing the morphological appearance of lactic acid bacteria by SEM photograph of Lactobacillus lambosus HK-9.
FIG. 4 is a graph showing the cell concentration of Lactobacillus laminocus HK-9 using the MRS medium over time. FIG.
5 is a graph showing ginsenoside content of ginseng following fermentation of Lactobacillus lambosus strain HK-9 and other common strains.
FIG. 6 is a graph showing the result of the production of a new substance in the broth fermented using Lactobacillus lambosus HK-9. FIG.
7 is a graph showing the results of DPPH activity before and after fermentation of the above fermented broccoli.
8 and 9 show results of the whitening-related efficacy experiments of Lactobacillus lambosus strain HK-9 itself, FIG. 8 shows the melanin synthesis inhibition activity experiment, FIG. 9 shows the tyrosinase inhibition experiment Fig.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명한다.
Hereinafter, the present invention will be described in more detail by way of examples.
실시예 1. 유산균 분리 방법Example 1. Method for isolating lactic acid bacteria
신규한 유산균의 분리를 위해 20~40대 남여 40명에게 실험실시 약 7일 전에 참여하도록 요청하였으며, 실험을 실시하기 전 실험에 참여할 참가자들이 따로 세척 및 처리를 하지 않도록 불특정일에 실험을 실시하였다.In order to isolate the new lactic acid bacteria, 40 people in their 20s and 40s were asked to participate in the experiment about 7 days before the experiment. Experiments were carried out on the unspecified day .
미리 제작한 MRS Agar 배지에 실험 참자가의 손바닥을 찍어서 초기 미생물을 접종하였다. 접종된 초기 샘플은 30℃에서 24시간 동안 배양한 후, 얻어진 미생물 콜로니를 다시 MRS Agar 배지에 2차 접종을 하여 균주를 얻어냈다. 2차 접종에서 얻어진 콜로니별로 발효를 한 결과 가장 활성이 뛰어난 미생물을 선택하였다.The initial microorganisms were inoculated into the previously prepared MRS Agar medium by the palms of the experimental subjects. The inoculated initial samples were cultured at 30 ° C for 24 hours, and the obtained microorganism colonies were inoculated again onto the MRS agar medium to obtain strains. The most active microorganisms were selected as a result of fermentation by each colony obtained from the second inoculation.
상기의 방법으로 얻어진 미생물을 한국미생물보존센터에 의뢰하여, PCR을 이용하여 유산균을 식별하였으며 그 결과를 도 1(16S rDNA의 염기서열, 서열은 서열목록 1로 첨부)과 도 2(계통분류학적 위치)에 나타내었다.The microorganisms obtained by the above method were referred to the Korean Microorganism Preservation Center and lactic acid bacteria were identified using PCR. The results are shown in Fig. 1 (base sequence of 16S rDNA, sequence is attached to Sequence Listing 1) and Fig. 2 Position).
한국 미생물보존센터의 결과로 본 발명에서 얻어진 균주는 락토바실러스 (Lactobacillus) 속의 균주인 것을 확인할 수 있었다. 발명자들은 위 균주를 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9라 명명하였으며, 이 균주를 2012. 2. 17. 한국미생물보존센터(Korean Culture Center of Microorganism)에 기탁번호 KCCM11254P로 기탁하였다.As a result of the Korean Microorganism Conservation Center, it was confirmed that the strain obtained in the present invention is a strain belonging to the genus Lactobacillus . The inventors named the above strain Lactobacillus rhamnosus strain HK-9 and deposited this strain with the deposit number KCCM11254P on Feb. 21, 2012 at the Korean Culture Center of Microorganism.
신규 균주 락토바실러스 람노서스 HK-9의 SEM 사진을 통해 확인한 유산균의 형태는 도 3에 나타내었다.
The morphology of the lactic acid bacteria confirmed by the SEM photograph of the new strain Lactobacillus lambosus HK-9 is shown in Fig.
실시예 2. 유산균 배양 방법Example 2. Culture method of lactic acid bacteria
실시예 1을 통해 분리된 유산균을 MRS 배지에 배양하여, 균주의 특성에 맞는 최적 배양 시간을 정하였다. 배양 방법은 일반적인 유산균 배양 방법으로 55%의 MRS 배지와 0.5%의 L-Cysteine hydrochloride를 첨가하여 배지를 제작하였으며, 배양 온도는 36℃로 하였고, 발효 균주 특성상 밀봉된 형태로 혐기성 조건에서 실험을 하여야 하기 때문에 최소한의 교반속도(50~60rpm)로 배양하여 72시간 동안 1L의 플라스크에서 400ml의 부피로 실험을 하였다.The lactic acid bacteria isolated in Example 1 were cultured in MRS medium and the optimal culture time was determined according to the characteristics of the strain. The culture medium was prepared by adding 55% of MRS medium and 0.5% of L-cysteine hydrochloride to the culture medium. The incubation temperature was 36 ° C. and the experiment was carried out under anaerobic conditions in the form of a sealed fermentation strain Therefore, the culture was carried out at a minimum stirring speed (50 to 60 rpm), and the volume of the flask was 400 ml in a 1 L flask for 72 hours.
상기의 방법으로 배양한 락토바실러스 람노서스 HK-9 균주의 시간에 따른 균체 농도를 나타낸 결과를 도 4에 나타내었다. 결과에 따르면 12시간까지 배양하였을 때 균체의 농도가 약 644 x 106의 양으로 존재하지만, 12시간이 지나 24시간까지 배양하였을 경우 최고 농도인 3255 x 106의 양으로 증가되고, 48시간까지 균체 농도가 유지되며, 48시간이 지난 이후 균체가 서서히 감소하는 것을 확인할 수 있다.FIG. 4 shows the cell concentration of Lactobacillus lambosus strain HK-9 cultured by the above method. According to the results, when the cells were cultured up to 12 hours, the cells were present at an amount of about 644 x 10 6 , but when they were cultured for 12 hours to 24 hours, the maximum concentration was increased to 3255 x 10 6 , The cell concentration was maintained, and after 48 hours, the cells were gradually reduced.
따라서, 본 발명의 락토바실러스 람노서스 HK-9 균주의 최적 배양 시간을 48시간으로 결정하였다.
Therefore, the optimum incubation time of the Lactobacillus lambosus strain HK-9 of the present invention was determined to be 48 hours.
실시예 3. 천연물의 발효를 통한 유효 생리활성 증진 검증Example 3. Validation of Enhancement of Effective Physiological Activity through Fermentation of Natural Products
1) 파삼 발효물의 진세노사이드 함량 분석1) Analysis of ginsenoside content of fermented pancake
상기의 분리해낸 락토바실러스 람노서스 HK-9 균주를 이용하여 파삼을 발효하였다. 발효 방법으로서, 2L 플라스크에 100g의 파삼을 파우더 형태로 갈아서 첨가한 후, 1L의 배양 배지를 만든 후 락토바실러스 람노서스 HK-9 균주를 5% 접종하여 48시간 동안 발효시켰다.The thus-isolated Lactobacillus lambosus strain HK-9 was used to ferment the panting. As a fermentation method, 100 g of pansam was added in a powder form to a 2 L flask, and then 1 L of a culture medium was prepared. Then, Lactobacillus lambosus strain HK-9 was inoculated 5% and fermented for 48 hours.
또한, 락토바실러스 람노서스 HK-9 균주와 함께 Lactobacillus rhamnosus GG, Lactobacillus paracasei, Lactobacillus casei, Lactobacillus acidophilus Plantarum + Bifidobacterium lactis Longum 균주를 대조군으로 하여 상기의 락토바실러스 람노서스 HK-9 균주와 같은 방법으로 배양하였다. In addition, Lactobacillus rhamnosus GG, Lactobacillus paracasei, Lactobacillus casei and Lactobacillus acidophilus Plantarum + Bifidobacterium lactis Longum strains were used as a control group together with Lactobacillus lambosus strain HK-9 in the same manner as Lactobacillus lambosus strain HK-9 .
진세노사이드 분석을 위해 발효물을 파우더 형태로 만든 후, 부탄올 추출법을 이용하여 토탈 사포닌 함량(Rg3+Rg2+Rh2+CK+Rg1+Rb1+Rb2+Rc+Re+Rd)을 측정하였다.The total saponin content (Rg3 + Rg2 + Rh2 + CK + Rg1 + Rb1 + Rb2 + Rc + Re + Rd) was measured by using the butanol extraction method after making the fermented product into powder form for ginsenoside analysis.
도 5의 유산균 종류에 따른 파삼 발효 시 진세노사이드 함량 결과에서 알 수 있듯이, 본 발명의 유산균인 락토바실러스 람노서스 HK-9 균주에서 가장 많은 양의 진세노사이드가 검출된 것을 확인할 수 있었으며, 보통의 유산균보다 최대 200%까지 높은 효율을 보이는 것을 알 수 있었다.
As can be seen from the results of the content of ginsenosides in the fermentation of the pancake according to the lactic acid bacteria of FIG. 5, it was confirmed that the highest amount of ginsenoside was detected in the Lactobacillus lambosus strain HK-9, which is the lactic acid bacterium of the present invention, Of lactic acid bacteria up to 200%.
2) 황금 발효물의 항산화 활성 실험2) Antioxidant activity test of golden fermented product
황금의 발효물은 파삼의 발효와 같은 방법으로 하였다. 2L 플라스크에 100g의 황금을 파우더 형태로 갈아서 첨가한 후, 1L의 배양 배지를 만든 후 락토바실러스 람노서스 HK-9 균주를 5% 접종하여 48시간 동안 발효를 하였다.The fermented product of gold was made by the same method as the fermentation of pansam. In a 2 L flask, 100 g of gold was ground and added to a 1 L culture medium, followed by 5% inoculation with Lactobacillus lambosus strain HK-9 and fermentation for 48 hours.
또한, 락토바실러스 람노서스 HK-9 균주와 함께 Lactobacillus rhamnosus GG, Lactobacillus paracasei, Lactobacillus casei 균주를 대조군으로 하여 상기의 락토바실러스 람노서스 HK-9 균주와 같은 방법으로 배양하였다.In addition, Lactobacillus rhamnosus GG, Lactobacillus paracasei, and Lactobacillus casei strains were used as a control in combination with Lactobacillus lambosus strain HK-9 and cultured in the same manner as the Lactobacillus lambosus strain HK-9.
향장활성 실험을 위해 발효액을 동결건조한 후 파우더 형태로 만들어서 측정 하였으며, 각각 DPPH 소거 활성 측정, 환원력 측정, 총 페놀 함량 측정 실험을 하였다. 그 결과는 표 1과 같다.
For the experiment of fermentation activity, the fermentation broth was prepared by lyophilization and powdered. The DPPH scavenging activity, reducing power and total phenol content were measured. The results are shown in Table 1.
상기의 표 1.의 황금의 항산화 활성 실험을 통해 본 발명의 유산균인 락토바실러스 람노서스 HK-9 균주의 항산화 활성이 뛰어난 것을 확인할 수 있었다.The antioxidant activity of Lactobacillus lambosus strain HK-9, which is a lactic acid bacterium of the present invention, was confirmed to be superior in antioxidant activity of gold in Table 1 above.
특히, 항산화 활성 중 총 페놀 함량의 결과는 다른 유산균을 통해 발효한 황금보다 2~4배 정도 높은 활성을 보이는 것을 확인할 수 있다. 이러한 결과를 바탕으로 본 발명의 유산균인 락토바실러스 람노서스 HK-9 균주의 향장 활성(노화방지와 관련 있는 항산화 활성)이 존재하는 것을 확인할 수 있으며, 이는 여자 손으로부터 분리를 한 것과도 관련이 있는 것으로 보인다.Especially, the results of total phenol content of antioxidant activity showed 2 ~ 4 times higher activity than gold fermented by other lactic acid bacteria. Based on these results, it can be confirmed that the lactic acid bacteria of the present invention, Lactobacillus lambosus strain HK-9, has a fungal activity (antioxidative activity related to anti-aging), which is also related to the separation from the female hand Seems to be.
이러한 결과로 보아 락토바실러스 람노서스 HK-9 균주를 통해 발효를 할 경우 다른 유산균에 비해 발효에 따른 유용생리활성의 용출이 용이하며 향장활성도 뛰어난 것을 알 수 있다.
From these results, it can be seen that fermentation through Lactobacillus lambosus strain HK-9 facilitates dissolution of useful physiological activity and fermentation activity by fermentation compared to other lactic acid bacteria.
3) 더덕의 발효에 따른 새로운 물질의 생성3) Generation of new substances by fermentation
발명자들은 본 발명에 따른 균주를 이용해 더덕의 발효 전후의 생리활성 물질의 변화를 측정해 보았다.The inventors measured the change of physiologically active substance before and after fermentation of the dodec using the strain according to the present invention.
발효 전 더덕은 생더덕을 열풍건조기를 이용하여 40℃의 온도에서 24시간 동안 건조한 후, 볼밀을 이용하여 2~3mm의 크기로 분쇄한 후 70% 에탄올로 추출한 것을 이용하였다.Before fermentation, Doduck was dried in a hot air drier at 40 ℃ for 24 hours, and then pulverized into 2 ~ 3mm using a ball mill and extracted with 70% ethanol.
또한, 발효 더덕은 상기의 파삼의 발효와 같은 방법으로 발효하여 건조한 더덕 100g을 파우더 형태로 갈아서 2L 플라스크에 첨가한 후, 1L의 배양 배지를 만든 후 락토바실러스 람노서스 HK-9 균주를 5% 접종하여 48시간 동안 발효를 하였다.
In addition, fermented Doduck was fermented in the same manner as the above-mentioned fermentation of the above-mentioned phage, and 100 g of dried Doduck was ground into a powder form and added to a 2 L flask. Then, 1 L of a culture medium was prepared and then Lactobacillus lambosus strain HK-9 was inoculated 5% And fermented for 48 hours.
상기의 방법을 통해 준비한 더덕의 HPLC 분석 결과를 도 6에 나타내었다. 도 6의 결과로 보아 발효 전의 더덕에는 2.7분경의 피크 하나만 검출되나 발효 후에는 2.7분경에 검출된 피크와 함께 3.1분에 신규한 피크가 더 검출되는 것을 확인할 수 있었다. The results of HPLC analysis of dodec prepared by the above method are shown in FIG. From the results of FIG. 6, only one peak at 2.7 minutes was detected in the broth before fermentation, but a new peak was detected at 3.1 minutes along with the peak detected at 2.7 minutes after fermentation.
이러한 신규한 피크의 물질은 새로운 생리 활성을 나타내는 물질로서, 발효 전 더덕과 발효 후 더덕의 DPPH 활성을 나타낸 도 7에서 볼 수 있듯이 발효를 통해 더덕의 DPPH 활성이 높아진 것을 확인할 수 있으며, 이로써 락토바실러스 람노서스 HK-9 균주의 발효를 통해서 생긴 신규한 물질이 DPPH 활성에 영향을 주는 것을 확인할 수 있다.
As shown in FIG. 7 showing the DPPH activity of fermentation broth and fermented broodstock after fermentation, these novel peaks exhibit a new physiological activity. As a result, it can be confirmed that DPPH activity of broodstock increased by fermentation, It can be confirmed that a novel substance produced through the fermentation of Lymphocus strain HK-9 has an effect on DPPH activity.
4) 락토바실러스 람노서스 HK-9 균주 자체에 따른 향장 활성 능력 측정4) Measurement of the activity of the fungus activity according to the Lactobacillus Lymphosus strain HK-9 itself
락토바실러스 람노서스 HK-9 균주 자체에서 나오는 향장활성 물질의 효능을 측정하기 위해 멜라닌 합성 저해능(Melanin synthesis inhibition activity) 실험과 티로시네이즈 저해(Tyrosinase inhibition) 실험을 하였다.Melanin synthesis inhibition activity and tyrosinase inhibition experiments were carried out to determine the efficacy of the fragrant active substances from the Lactobacillus Lymphosus HK-9 strain itself.
먼저 락토바실러스 람노서스 HK-9 균주를 파쇄하기 위해 기존 MRS 배지에서 배양된 락토바실러스 람노서스 HK-9 균주를 원심분리하여 총 100ml의 균주를 확보하였다. 그 후, 균주를 20~50분 동안 초음파 처리하여 균주를 파쇄하였다. 파쇄된 균주와 그 액을 60℃에서 열수 추출을 하여 균주 추출액을 얻어서 향장활성 실험을 하였다.First, in order to disrupt Lactobacillus lambosus strain HK-9, Lactobacillus lambosus strain HK-9 cultivated in a conventional MRS medium was centrifuged to obtain a total of 100 ml of strain. The strain was then sonicated for 20 to 50 minutes to disrupt the strain. The shattered strain and its solution were subjected to hot - water extraction at 60 ℃ to obtain a strain extract.
도 8은 멜라닌 합성 저해능(Melanin synthesis inhibition activity)을 나타낸 결과이다. 멜라노사이트(melanocyte)인 Clon-M3 세포를 이용하여 시료 투여 시 멜라닌 생합성과 세포 생존율에 미치는 영향을 관찰하기 위하여 농도별로 처리하고 24 시간이 지난 후 멜라닌 생성 저해율을 측정하였다. 측정 결과 12.5 mg/ml에서 100mg/ml로 갈수록 저해율이 높아지는 것을 확인할 수 있었으며, 최종적으로 약 40%에 달하는 저해율을 보였다. 이러한 결과는 락토바실러스 람노서스 HK-9 균주의 균주 자체의 성분에서 멜라닌 생성을 감소시키는 효과가 있다는 것을 보여준다.Figure 8 shows the results of the melanin synthesis inhibition activity. In order to observe the effects on the melanin biosynthesis and cell viability after administration of the sample using the melanocyte Clon-M3 cells, the inhibition rate of melanin formation was measured after 24 hours of treatment. As a result, it was confirmed that the inhibition rate was increased from 12.5 mg / ml to 100 mg / ml, and finally, the inhibition rate reached about 40%. These results show that the component of the strain of Lactobacillus lambosus strain HK-9 has an effect of reducing the production of melanin.
또한, 도 9는 티로시네이즈 저해(Tyrosinase inhibition)를 측정한 결과이다. 티로시네이즈는 피부 멜라닌 색소의 생성을 촉진시키는 효소로 티로시네이즈의 저해활성을 측정함으로써 미백 효과를 알아볼 수 있다. 도 9의 결과로 최종적으로 약 22%의 저해율을 나타내는 것을 확인할 수 있었다.9 is a result of measurement of tyrosinase inhibition. Tyrosinase is an enzyme that promotes the production of melanin pigment in the skin, and by measuring the inhibitory activity of tyrosinase, a whitening effect can be recognized. As a result of FIG. 9, it was confirmed that the inhibition rate was finally about 22%.
상기 결과는 일반적인 천연물을 이용한 멜라닌 저해율보다는 낮은 수치지만 균주 자체에서 향장활성을 가지는 성분이 함유되어 있다는 결정적인 실험 결과로서, 이를 통해 비싼 천연물을 이용하여 향장 제품을 생산하는 것보다 상대적으로 생산이 쉬운 발효 균주를 이용함으로써 더욱 경쟁력 있게 화장품 관련 원료 및 제품을 생산할 수 있을 것으로 기대된다.
This result is a result of a definite experiment that contains a component having a fumaric activity in the strain itself, which is lower than the rate of inhibition of melanin using a natural product. Thus, it is possible to produce relatively easy fermentation By using the strain, it is expected to be able to produce cosmetics-related raw materials and products more competitively.
서열목록 전자파일 첨부Attach an electronic file to a sequence list
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120055971A KR101388918B1 (en) | 2012-05-25 | 2012-05-25 | Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120055971A KR101388918B1 (en) | 2012-05-25 | 2012-05-25 | Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130131968A KR20130131968A (en) | 2013-12-04 |
KR101388918B1 true KR101388918B1 (en) | 2014-05-07 |
Family
ID=49980983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120055971A Active KR101388918B1 (en) | 2012-05-25 | 2012-05-25 | Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101388918B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230000126A (en) | 2021-06-24 | 2023-01-02 | 제주대학교 산학협력단 | Composition of complex fermentation products as an active ingredient using microorganisms in Lactobacillus genus for the improving liver function |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101889647B1 (en) * | 2017-02-18 | 2018-08-20 | 박병희 | Novel Lactobacillus Harbinensis and Use thereof |
CN108125905A (en) * | 2018-02-18 | 2018-06-08 | 王甲林 | A kind of whitening emulsion with Lactobacillus rhamnosus fermentation activity ingredient |
CN108410761B (en) * | 2018-03-06 | 2020-03-20 | 山东凤凰生物有限公司 | Lactobacillus rhamnosus with nitrite reducing and oxidation resisting functions and screening and separating method |
KR102116869B1 (en) * | 2018-07-19 | 2020-05-29 | (주)다럼앤바이오 | Cosmetic composition comprising fermented extract of mistletoe for improving skin wrinkle |
KR102145447B1 (en) * | 2018-08-28 | 2020-08-18 | (주)다럼앤바이오 | Cosmetic compositions containing fermented extract of Hippophae rhamnoides L |
KR101961149B1 (en) * | 2018-11-30 | 2019-03-25 | 주식회사 아미코스메틱 | Lactobacillus paraplantarum ami-1101 and use thereof |
KR102074383B1 (en) * | 2019-04-26 | 2020-02-06 | 주식회사 락토메이슨 | Skin-whitening cosmetic composition comprising lactobacillus rhamnosus lm1011 having immunostimulating activity |
KR102192446B1 (en) * | 2020-02-28 | 2020-12-18 | 조선대학교 산학협력단 | Cosmetical composition, pharmaceutical composition and health functional food |
CN114717131B (en) * | 2021-09-07 | 2023-05-26 | 青岛蔚蓝生物股份有限公司 | Lactobacillus rhamnosus with skin injury protecting effect and application thereof |
CN115444792B (en) * | 2022-08-10 | 2023-08-18 | 山东朵拉朵尚生物科技有限公司 | Ginseng fermentation liquor with anti-wrinkle tightening effect and preparation method and application thereof |
KR102788836B1 (en) * | 2022-12-28 | 2025-03-31 | 선문대학교 산학협력단 | Cosmetic composition for anti-oxidation, skin whitening and anti-wrinkle containing a mixed fermentation extracts of Oryza sativa callus and sprout barley as effective component |
CN116042474B (en) * | 2022-12-30 | 2024-07-26 | 华熙生物科技股份有限公司 | Lactobacillus rhamnosus and application thereof |
CN116211903A (en) * | 2023-04-13 | 2023-06-06 | 济南济宇生物工程有限责任公司 | Radix glehniae fermented product, water extract, product and application thereof |
-
2012
- 2012-05-25 KR KR1020120055971A patent/KR101388918B1/en active Active
Non-Patent Citations (2)
Title |
---|
Journal of Pharmacopuncture, Vol.13, pp.33-49(2010.06.) |
한국식품과학회지, Vol.44, pp.135-139(2012.02.)* |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230000126A (en) | 2021-06-24 | 2023-01-02 | 제주대학교 산학협력단 | Composition of complex fermentation products as an active ingredient using microorganisms in Lactobacillus genus for the improving liver function |
Also Published As
Publication number | Publication date |
---|---|
KR20130131968A (en) | 2013-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101388918B1 (en) | Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it | |
KR101627850B1 (en) | Method of fermentation using complex strains and cosmetic composition comprising thereof | |
KR100618171B1 (en) | Fermented red ginseng containing ginseng saponin degradate and its manufacturing method | |
KR100716133B1 (en) | Garlic material for health promotion and its manufacturing method with mild irritant flavor | |
KR101718465B1 (en) | Novel Lactobacillus Casei GFC 1 and Extracts from Ginseng-fermented Products Using Lactobacillus Casei GFC 1 and Manufacturing Method Thereof | |
CN113604395B (en) | Lactobacillus plantarum capable of fermenting dendrobium nobile and improving skin quality by fermentation liquor thereof | |
TWI689585B (en) | Novel lactic acid strain and immune activating agent containing novel lactic acid strain | |
KR101628756B1 (en) | Novel Lactobacillus pentosus NEO 1 and extracts from ginseng-fermented products using Lactobacillus pentosus NEO 1 and manufacturing method thereof | |
KR101647631B1 (en) | Composition for ginsenoside bioconversion comprising Lactobacillus plantarum WIKIM18 | |
KR101343410B1 (en) | Novel Lactobacillus plantarum CRNB-22 (KCTC 11931 BP) strain capable of fermenting ginseng and method of transforming saponin using thereof | |
WO2011141762A1 (en) | Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei | |
Havas et al. | Performances of new isolates of Bifidobacterium on fermentation of soymilk | |
WO2013176320A1 (en) | Human-derived lactobacillus rhamnosus hk-9, and fermented product and cosmetic composition using same | |
KR101194226B1 (en) | Cosmetic composition for antioxidant and whitening effects having fermented paprika extract and manufacturing method thereof | |
KR102097509B1 (en) | Novel lactic acid bacteria and method of preparing fermented product having effect of anti-obesity and anti-diabets using the same | |
CN106901336A (en) | A kind of plateau ferment zymotechnique | |
KR20130107940A (en) | Method of producing fermented red ginseng | |
CN111349678A (en) | Extraction method of rape pollen polysaccharide and extraction product | |
CN111500642B (en) | Blueberry fermentation product and preparation method and application thereof | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
CN114032190A (en) | Lactobacillus reuteri capable of fermenting dendrobium and effectively repairing solar dermatitis by fermentation liquor of dendrobium | |
KR102011133B1 (en) | Lactobacillus plantarum MBE/L2990 strain having excellent alpha-rhamnosidase activity and bioconversion activity from ginsenoside Re and Rb1 to ginsenoside Rg1 and Rg5 | |
KR20120094293A (en) | Manufacturing method for fermented dioscorea using latic acid fermentation | |
KR102218224B1 (en) | Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient | |
JP2019170246A (en) | Methods for producing fermented products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20120525 |
|
PA0201 | Request for examination | ||
N231 | Notification of change of applicant | ||
PN2301 | Change of applicant |
Patent event date: 20120824 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20131119 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20140322 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20140423 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20140423 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20170329 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20170329 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180410 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20180410 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190321 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20190321 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20210420 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20220426 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20230321 Start annual number: 10 End annual number: 10 |